108 related articles for article (PubMed ID: 1394062)
1. Soluble interleukin-2 receptor serum levels in mycosis fungoides. Correlation with clinical stage.
Szeimies RM; Rueff F; Kaudewitz P
Cancer; 1992 Nov; 70(9):2338-41. PubMed ID: 1394062
[TBL] [Abstract][Full Text] [Related]
2. A correlation between acute phase proteins and cytokines in patients suffering from mycosis fungoides.
Pawlaczyk M; Sobieska M
Acta Dermatovenerol Alp Pannonica Adriat; 2006 Sep; 15(3):107-12. PubMed ID: 17053844
[TBL] [Abstract][Full Text] [Related]
3. Increased interleukin-36γ expression in skin and sera of patients with atopic dermatitis and mycosis fungoides/Sézary syndrome.
Otobe S; Sugaya M; Nakajima R; Oka T; Takahashi N; Kabasawa M; Miyagaki T; Asano Y; Sato S
J Dermatol; 2018 Apr; 45(4):468-471. PubMed ID: 29314201
[TBL] [Abstract][Full Text] [Related]
4. Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides.
Kakinuma T; Sugaya M; Nakamura K; Kaneko F; Wakugawa M; Matsushima K; Tamaki K
J Am Acad Dermatol; 2003 Jan; 48(1):23-30. PubMed ID: 12522366
[TBL] [Abstract][Full Text] [Related]
5. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
Srivastava MD; Srivastava A; Srivastava BI
Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
[TBL] [Abstract][Full Text] [Related]
6. Differences in IL-2 receptor levels between mycosis fungoides and cutaneous type adult T-cell leukemia/lymphoma in the early stages of the disease.
Oishi M; Johno M; Ono T; Honda M
J Invest Dermatol; 1994 May; 102(5):710-5. PubMed ID: 8176252
[TBL] [Abstract][Full Text] [Related]
7. Soluble interleukin-2 receptor in Sézary syndrome: its origin and clinical application.
Bernengo MG; Fierro MT; Novelli M; Lisa F; Appino A
Br J Dermatol; 1993 Feb; 128(2):124-9. PubMed ID: 8457444
[TBL] [Abstract][Full Text] [Related]
8. Serum IL-31 levels are increased in patients with cutaneous T-cell lymphoma.
Ohmatsu H; Sugaya M; Suga H; Morimura S; Miyagaki T; Kai H; Kagami S; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Acta Derm Venereol; 2012 May; 92(3):282-3. PubMed ID: 22456907
[No Abstract] [Full Text] [Related]
9. Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implications.
Wasik MA; Vonderheid EC; Bigler RD; Marti R; Lessin SR; Polansky M; Kadin ME
Arch Dermatol; 1996 Jan; 132(1):42-7. PubMed ID: 8546482
[TBL] [Abstract][Full Text] [Related]
10. Serum interleukin-15 levels are not elevated in patients with stage I and II mycosis fungoides.
Sugaya M; Nakamura K; Tamaki K
Acta Derm Venereol; 2000; 80(6):455. PubMed ID: 11243648
[No Abstract] [Full Text] [Related]
11. [Serum levels of soluble receptors of interleukin-2 in skin pathology].
Massobrio R; Lisa F; Novelli M; Bernengo MG
G Ital Dermatol Venereol; 1990 Feb; 125(1-2):1-6. PubMed ID: 2365399
[TBL] [Abstract][Full Text] [Related]
12. Dupilumab-associated mycosis fungoides: a cross-sectional study.
Hamp A; Hanson J; Schwartz RA; Lambert WC; Alhatem A
Arch Dermatol Res; 2023 Nov; 315(9):2561-2569. PubMed ID: 37270763
[TBL] [Abstract][Full Text] [Related]
13. Presence of circulating CCR10+ T cells and elevated serum CTACK/CCL27 in the early stage of mycosis fungoides.
Fujita Y; Abe R; Sasaki M; Honda A; Furuichi M; Asano Y; Norisugi O; Shimizu T; Shimizu H
Clin Cancer Res; 2006 May; 12(9):2670-5. PubMed ID: 16675558
[TBL] [Abstract][Full Text] [Related]
14. Hypomagnesemia and hypocalcemia in mycosis fungoides: a retrospective case series.
Morgan M; Maloney D; Duvic M
Leuk Lymphoma; 2002 Jun; 43(6):1297-302. PubMed ID: 12152999
[TBL] [Abstract][Full Text] [Related]
15. [The role of serum soluble interleukin 2 receptor (sIL-2R) levels in patients with renal cell carcinoma].
Akiyama K; Tsuji M; Kurokawa Y; Yokota K; Kojima K; Naruo S; Kanayana HO; Kagawa S
Nihon Hinyokika Gakkai Zasshi; 1997 Apr; 88(4):473-8. PubMed ID: 9155114
[TBL] [Abstract][Full Text] [Related]
16. Mycosis Fungoides and Its Relationship to Atopy, Serum Total IgE, and Eosinophil Counts.
Vonderheid EC; Hamilton RG; Kadin ME
Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):279-288.e7. PubMed ID: 33342729
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of serum adenosine deaminase activity in patients with mycosis fungoides.
Koizumi H; Tomizawa K; Tanaka H; Kumakiri M; Ohkawara A
J Dermatol; 1993 Jul; 20(7):394-9. PubMed ID: 8408919
[TBL] [Abstract][Full Text] [Related]
18. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
López-Lerma I; Estrach MT
J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the IL-31 pathway in Mycosis fungoides and Sézary syndrome.
Möbs M; Gryzik S; Haidar A; Humme D; Beyer M; Vandersee S
Arch Dermatol Res; 2015 Aug; 307(6):479-85. PubMed ID: 25488078
[TBL] [Abstract][Full Text] [Related]
20. Tumor stage mycosis fungoides in a patient treated with long-term corticosteroids for asthma and atopic-like dermatitis.
Abel EA; Nickoloff BJ; Shelby DM; Watson W; Wood GS
J Dermatol Surg Oncol; 1986 Oct; 12(10):1089-93. PubMed ID: 3489744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
